跳至主要内容
临床试验/JPRN-UMIN000042070
JPRN-UMIN000042070招募中未知

Preventive effects of lemborexant on postoperative delirium in patients with proximal femur fracture surgery and insomnia in the perioperative period: a double-blind, randomized, non-inferiority trial of lemborexant versus ramelteon - Preventive effects of lemborexant on postoperative delirium in patients with proximal femur fracture surgery and insomnia in the perioperative period: a double-blind, randomized, non-inferiority trial of lemborexant versus ramelteon

Fujita Health University School of Medicine0 个研究点目标入组 198 人开始时间: 2020年10月12日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients taking CYP1A2 inhibitors (quinolone antibacterial drug, fluvoxamine), CYP3A4 inhibitors (itraconazole, ketraconazole, fluconazole, verapamil, macrolide antibiotics), CYP3A4 inducers (phenytoin, rifampicin), and central nervous system depressants (barbituric acid derivatives, phenothiazine derivatives) Patients taking lemborexant, ramelteon Patients who already have impaired consciousness Patients with serious physical illness Patients with a history of hypersensitivity to the components of lemborexant or ramelteon Others: patients judged to be inappropriate by the principal investigator or coordinator

研究者

发起方
Fujita Health University School of Medicine

相似试验